The cell surface vimentin antibody was used for circulating tumor cells (CTCs) detection and CD133 antibody for CCSC detection.
[Lung Cancer]
6445212 {6445212:SCNQXKEH} apa 50 1 161642 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-61feeb36c7f8cb4147c76fb7d7d35ecb%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22SCNQXKEH%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hsu%20et%20al.%22%2C%22parsedDate%22%3A%222021-06-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EHsu%2C%20C.-L.%2C%20Tsai%2C%20T.-H.%2C%20Huang%2C%20C.-K.%2C%20Yang%2C%20C.-Y.%2C%20Liao%2C%20W.-Y.%2C%20Ho%2C%20C.-C.%2C%20Ruan%2C%20S.-Y.%2C%20Chen%2C%20K.-Y.%2C%20Shih%2C%20J.-Y.%2C%20%26amp%3B%20Yang%2C%20P.-C.%20%282021%29.%20Monitoring%20levels%20of%20vimentin-positive%20circulating%20cancer%20stem%20cells%20and%20tumor%20cells%20in%20patients%20with%20advanced%20EGFR-mutated%20non-small%20cell%20lung%20cancer.%20%3Ci%3ELung%20Cancer%3C%5C%2Fi%3E%2C%20%3Ci%3E156%3C%5C%2Fi%3E%2C%2050%26%23x2013%3B58.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lungcan.2021.04.014%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lungcan.2021.04.014%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3DSCNQXKEH%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Monitoring%20levels%20of%20vimentin-positive%20circulating%20cancer%20stem%20cells%20and%20tumor%20cells%20in%20patients%20with%20advanced%20EGFR-mutated%20non-small%20cell%20lung%20cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chia-Lin%22%2C%22lastName%22%3A%22Hsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tzu-Hsiu%22%2C%22lastName%22%3A%22Tsai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chun-Kai%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ching-Yao%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei-Yu%22%2C%22lastName%22%3A%22Liao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chao-Chi%22%2C%22lastName%22%3A%22Ho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sheng-Yuan%22%2C%22lastName%22%3A%22Ruan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kuan-Yu%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jin-Yuan%22%2C%22lastName%22%3A%22Shih%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pan-Chyr%22%2C%22lastName%22%3A%22Yang%22%7D%5D%2C%22abstractNote%22%3A%22%3Ch2%3EAbstract%3C%5C%2Fh2%3E%3Ch3%3EObjectives%3C%5C%2Fh3%3E%3Cp%3ECirculating%20tumor%20cells%20%28CTCs%29%20are%20associated%20with%20tumor%20spread%2C%20whereas%20cancer%20stem%20cells%20may%20be%20related%20to%20drug%20resistance.%20However%2C%20few%20studies%20have%20analyzed%20the%20levels%20of%20circulating%20cancer%20stem%20cells%20%28CCSCs%29%20and%20CTCs%20in%20patients%20with%20advanced%20non-small%20cell%20lung%20cancer%20%28NSCLC%29.%3C%5C%2Fp%3E%3Ch3%3EMaterials%20and%20Methods%3C%5C%2Fh3%3E%3Cp%3ETreatment-na%5Cu00efve%20patients%20with%20%3Ci%3EEGFR%3C%5C%2Fi%3E-mutated%20NSCLC%20who%20received%20epidermal%20growth%20factor%20receptor%20tyrosine%20kinase%20inhibitor%20%28EGFR-TKI%29%20therapy%20were%20recruited%20prospectively.%20The%20cell%20surface%20vimentin%20antibody%20was%20used%20for%20CTC%20detection%20and%20CD133%20antibody%20for%20CCSC%20detection.%20CCSC%20and%20CTC%20levels%20were%20measured%20as%20cell%20count%20per%204%20mL%20of%20blood%2C%20before%20treatment%2C%20after%202%20and%2012%20weeks%20of%20treatment%2C%20and%20at%20disease%20progression.%20Data%20on%20clinical%20characteristics%20and%20outcomes%20were%20also%20collected.%3C%5C%2Fp%3E%3Ch3%3EResults%3C%5C%2Fh3%3E%3Cp%3EAt%20diagnosis%20%28n%20%3D%2029%29%2C%20the%20median%20CCSC%20and%20CTC%20levels%20were%200%20%28interquartile%20range%2C%200%5Cu20132%29%20and%203%20%282%5Cu20139%29%2C%20respectively.%20After%2012%20weeks%2C%20the%20CCSC%20and%20CTC%20levels%20were%20lower%20than%20those%20at%20diagnosis%20%28CCSC%3A%200%20%280%5Cu22120%29%2C%20%3Ci%3Ep%3C%5C%2Fi%3E%20%3D%200.14%3B%20CTC%3A%201%20%280%5Cu20134%29%2C%20%3Ci%3Ep%3C%5C%2Fi%3E%20%3D%200.048%29.%20At%20disease%20progression%2C%20the%20median%20CCSC%20and%20CTC%20levels%20were%200%20%280%5Cu20131%29%20and%201%20%280%5Cu20132%29%2C%20respectively.%20Patients%20with%20higher%20CCSC%20and%20CTC%20levels%20at%20diagnosis%20had%20a%20numerically%20shorter%20progression-free%20survival.%3C%5C%2Fp%3E%3Ch3%3EConclusion%3C%5C%2Fh3%3E%3Cp%3EIn%20patients%20with%20%3Ci%3EEGFR%3C%5C%2Fi%3E-mutated%20NSCLC%2C%20CCSC%20and%20CTC%20levels%20became%20lower%20after%2012%20weeks%20of%20EGFR-TKI%20therapy%20and%20remained%20low%20at%20disease%20progression.%20High%20pre-treatment%20CCSC%20and%20CTC%20levels%20may%20be%20associated%20with%20a%20trend%20towards%20poor%20treatment%20outcomes.%3C%5C%2Fp%3E%22%2C%22date%22%3A%222021%5C%2F06%5C%2F01%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.lungcan.2021.04.014%22%2C%22ISSN%22%3A%220169-5002%2C%201872-8332%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.lungcancerjournal.info%5C%2Farticle%5C%2FS0169-5002%2821%2900155-0%5C%2Fabstract%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-04-28T20%3A06%3A34Z%22%7D%7D%5D%7D
Hsu, C.-L., Tsai, T.-H., Huang, C.-K., Yang, C.-Y., Liao, W.-Y., Ho, C.-C., Ruan, S.-Y., Chen, K.-Y., Shih, J.-Y., & Yang, P.-C. (2021). Monitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancer. Lung Cancer, 156, 50–58. https://doi.org/10.1016/j.lungcan.2021.04.014 Cite